skip to content
Primary navigation


DrugKineret® (anakinra) [Biovitrum AB]

September 2019

Therapeutic area - Auto-inflammatory diseases

Approval criteria

  • Patient has the diagnosis of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) AND
  • Patient has negative tuberculin test or, if positive, therapy with isoniazid was initiated at least 1 month prior to request AND
  • Patient does not have an active infection or a history of recurring infections AND
  • Patient is not taking tumor necrosis factor (TNF) inhibitors concomitantly


  • If the patient has the diagnosis of rheumatoid arthritis, refer to the PA criteria sheet, “Immunomodulators”

Quantity limit

  • Patients with NOMID: 8 mg/kg/day 
  • Patient’s most current body weight must be provided at time of request


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top